Cancer-related insomnia affects between 30% and 60% of cancer patients in different phases of treatment — during chemotherapy, radiotherapy, postoperatively, and even in remission. It is one of the most prevalent and most underestimated complaints in oncology: it impacts treatment adherence, immune function, quality of life, and survival. Hypnotics and benzodiazepines have limited efficacy and significant risks in this population (dependence, respiratory depression, drug interactions with chemotherapeutics). A network meta-analysis published in Frontiers in Neurology in 2024 offers the most complete comparative overview available on acupuncture interventions for this condition.
The study included 37 randomized clinical trials with 3,246 cancer patients with insomnia and compared 16 distinct interventions in a Bayesian network meta-analysis model. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI), which assesses sleep latency, duration, efficiency, disturbances, use of sleep medication, daytime dysfunction, and subjective sleep quality on a scale of 0–21 (higher scores indicate worse quality). The acupoints most frequently used in the studies with best results were systematically identified and reported.
STUDY DATA
Ranking of interventions: auriculotherapy leads by a wide margin
The most striking result of the NMA was the dominance of auriculotherapy combined with moxibustion, which reached a SUCRA of 98.98% — the highest among all 16 interventions evaluated. This means that, according to the model of indirect evidence, this combination has a 98.98% probability of being the most effective for cancer insomnia when compared with other modalities. Auriculotherapy alone ranked 2nd with SUCRA of 77.47%, confirming that auriculotherapy itself is the central component of greatest impact.
The other modalities evaluated included conventional acupuncture, electroacupuncture, acupuncture with moxibustion, and various combinations — all with SUCRA inferior to auricular approaches. This pattern suggests that ear points may have specific modulatory properties on sleep that go beyond the pathways activated by conventional body acupuncture — possibly through direct activation of the vagus nerve and connections with the nucleus of the solitary tract, which regulates the sleep-wake cycle.
Why cancer-related insomnia warrants specialized treatment
Insomnia in cancer patients is not simply “the anxiety of someone who is ill” — it has specific pathophysiologic components: elevation of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) by tumors and by chemotherapy, which directly disturb circadian rhythm; toxicity of chemotherapeutics on the central nervous system; uncontrolled pain; dyspnea; nausea; and physical deconditioning that compromises the homeostatic pressure for sleep. Acupuncture has been described as acting on multiple of these mechanisms: it may reduce pro-inflammatory cytokines, may modulate the HPA axis (reducing nocturnal cortisol), may increase serotonin and melatonin, and relieves pain and nausea that fragment sleep.
Frequently Asked Questions
Yes, auriculotherapy with seeds is a noninvasive intervention, with no pharmacologic interactions described in the available literature for usual chemotherapy regimens. The medical acupuncturist should coordinate the plan with the oncology team, especially in phases of cytopenia. When the patient has thrombocytopenia secondary to chemotherapy, it is recommended to use only seeds without excessive pressure and to avoid semi-permanent needles (press-tacks) until normalization of platelet count. The medical acupuncturist should be informed of the patient’s hematologic status.
The studies with the best results in this NMA used protocols of 4 to 8 weeks of treatment, with sessions 2–3 times per week. With auriculotherapy seeds that the patient keeps in the ear for 3–5 days, the effect extends between sessions. PSQI improvement is usually perceptible after 2–3 weeks of consistent treatment. For patients on chemotherapy, it is recommended to plan sessions considering infusion days.
The central auricular acupoints are the same (Shenmen, Xin/Heart), but the cancer protocol is expanded to include points that modulate the immune response and reduce systemic inflammation — such as the endocrine point, ACTH point, and kidney point. In addition, the cancer context frequently requires parallel approach to pain, nausea, and fatigue, which is done by integrating auriculotherapy with body acupuncture. Treatment intensity and frequency are also usually higher in cancer-related insomnia.
Fonte Original
Frontiers in Neurology(em inglês)Founded in 1989 by physicians trained at the University of São Paulo (USP) and specialized in China, CEIMEC is a Brazilian national reference in the teaching and practice of medical acupuncture. With more than 3,000 physicians trained over 35 years, it collaborates with HC-FMUSP and is recognized by the Brazilian Medical College of Acupuncture (CMBA/AMB).